Revolutionizing Drug Detection with Aptamer Technology

Empowering medical, forensic, and biotech sectors with faster, more precise, and cost-effective analyte detection tools.

Why Traditional Detection Tools Fall Short

Modern diagnostics and detection technologies are still heavily reliant on outdated tools—antibodies, chemical assays, and synthetic molecules—that come with significant limitations. These legacy solutions are often costly, inflexible, and prone to accuracy issues. For organizations seeking to innovate and scale, these shortcomings can stall progress and compromise results.

01.

High Development Costs & Limited Flexibility

Traditional tools like antibodies and enzymes are expensive to develop and slow to produce. Their rigid formats make it difficult to adapt to new detection platforms or emerging diagnostic needs.

02.

Inaccurate or Unreliable Detection

Conventional assays often lack the precision needed for high-stakes applications. Issues like cross-reactivity and false positives/negatives reduce reliability in both clinical and forensic environments.

03.

Costly Logistics & Short Shelf Life Reagents

Many legacy reagents require cold storage, have limited stability, and are expensive to manufacture at scale. These constraints make them impractical for low-resource settings or widespread deployment.

Let’s Advance Detection Technology Together

How Aptamer Technology Solves These Challenges

Our Aptamer Advantage

At Aptamer Innovation Hub, we’ve reimagined detection technology from the ground up. Our aptamer-based solutions address the limitations of traditional tools, delivering faster development, greater accuracy, and enhanced scalability. Built for modern applications, our technology empowers partners to innovate without compromise.

Technical

Overview

What Makes Our Aptamer Technology Unique

Our platform harnesses the power of aptamers—short, single-stranded DNA molecules engineered to bind with high precision to drug-related analytes. Unlike traditional detection tools, our technology is designed for adaptability, scalability, and seamless integration into modern diagnostic and forensic systems. Here’s what makes it different:

Stay Ahead in Detection Innovation

Subscribe to our newsletter for insights on aptamer technology, product updates, industry applications, and exclusive R&D opportunities' delivered straight to your inbox.

Industries We Support

Partnering with Innovators Across Sectors

Biotech
& Pharma

Accelerate drug development and therapeutic monitoring with fast, reliable analyte detection solutions tailored for modern pipelines.

Medical Device Companies

Integrate shelf-stable, scalable biosensors into point-of-care platforms for rapid diagnostics and real-time patient insights.

Forensic Science & Law Enforcement

Improve field and lab-based drug detection with high-precision tools that reduce false positives and support evidence integrity.

Contract Research Organisations

Outsource detection R&D with confidence—leverage our aptamer expertise to reduce risk and increase project efficiency.

Who We Are

Based at the University of Derby, the Aptamer Innovation Hub develops pioneering aptamer-based detection solutions to make drug monitoring more accurate, affordable, and scalable. We’re scientists, engineers, and innovators committed to building safer communities and improving lives.

Ana Flavia Belchior de Andrade

Senior Research Scientist

Thomas Illingworth

Lead Research Scientist

Mary-Anne Freckleton

Research Scientist

Roshita
Edward

Research Scientist

Rebecca Mallender

Principle Technical Lead

Let’s Advance Detection Technology Together

Are you developing next-gen diagnostic tools, forensic systems, or biosensing platforms? We’d love to hear from you. Whether you’re exploring aptamer integration, seeking a licensing partner, or need support with detection R&D—our team is here to help you move faster, smarter, and with greater precision.